These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Issues on the selection of non-inferiority margin in clinical trials. Hou Y, Wu XY, Li K. Chin Med J (Engl); 2009 Feb 20; 122(4):466-70. PubMed ID: 19302756 [Abstract] [Full Text] [Related]
24. Re-formulating non-inferiority trials as superiority trials: The case of binary outcomes. Durkalski VL, Berger VW. Biom J; 2009 Feb 20; 51(1):185-92. PubMed ID: 19197960 [Abstract] [Full Text] [Related]
25. Statistical tests based on new composite hypotheses in clinical trials reflecting the relative clinical importance of multiple endpoints quantitatively. Nishikawa M, Tango T, Ohtaki M. Biom J; 2009 Oct 20; 51(5):749-62. PubMed ID: 19777463 [Abstract] [Full Text] [Related]
26. Sample size estimation for non-inferiority trials of time-to-event data. Crisp A, Curtis P. Pharm Stat; 2008 Oct 20; 7(4):236-44. PubMed ID: 17583558 [Abstract] [Full Text] [Related]
27. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins. Dilba G, Bretz F, Hothorn LA, Guiard V. Stat Med; 2006 Apr 15; 25(7):1131-47. PubMed ID: 16217842 [Abstract] [Full Text] [Related]
29. [Statistical notes. Randomized controlled clinical trials of both superiority and non-inferiority: critical considerations]. Marubini E, Rebora P, Reina G. Ital Heart J Suppl; 2005 Jun 15; 6(6):361-4. PubMed ID: 16013427 [Abstract] [Full Text] [Related]
30. Non-inferiority trials: the 'at least as good as' criterion. Laster LL, Johnson MF. Stat Med; 2003 Jan 30; 22(2):187-200. PubMed ID: 12520556 [Abstract] [Full Text] [Related]
36. The effects of non-compliance on intent-to-treat analysis of equivalence trials. Sheng D, Kim MY. Stat Med; 2006 Apr 15; 25(7):1183-99. PubMed ID: 16220491 [Abstract] [Full Text] [Related]
37. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials. Lai TL, Shih MC, Zhu G. Stat Med; 2006 Apr 15; 25(7):1149-67. PubMed ID: 16189814 [Abstract] [Full Text] [Related]
38. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Lader EW, Cannon CP, Ohman EM, Newby LK, Sulmasy DP, Barst RJ, Fair JM, Flather M, Freedman JE, Frye RL, Hand MM, Jesse RL, Van de Werf F, Costa F, American Heart Association. Circulation; 2004 Jun 01; 109(21):e305-7. PubMed ID: 15173053 [No Abstract] [Full Text] [Related]
39. [Superiority, equivalence and not inferiority studies for clinical trials]. Attanasio E. Prof Inferm; 2006 Jun 01; 59(1):49-57. PubMed ID: 16824361 [Abstract] [Full Text] [Related]
40. Clinical trials, immunosuppression and renal transplantation: new trends in design and analysis. Landais P, Daures JP. Pediatr Nephrol; 2002 Aug 01; 17(8):573-84. PubMed ID: 12185461 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]